Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs

	Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs
发表期刊	CELL PROLIFERATION
	2020
卷号	53 期号:12 页码:e12944
	Wu J(吴骏); Zhou Xing; Tan YQ(谭元卿); Wang L(王柳); Li TD(李天达); Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Li W(李伟); Hao J(郝捷); Wang Xianguang; Hu BY(胡宝洋)
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/14488
专题	干细胞与生殖生物学国家重点实验室
推荐引用方式 GB/T 7714	Wu J,Zhou Xing,Tan YQ,et al. Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs[J]. CELL PROLIFERATION,2020,53(12):e12944.
APA	吴骏.,Zhou Xing.,谭元卿.,王柳.,李天达.,...&胡宝洋.(2020).Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.CELL PROLIFERATION,53(12),e12944.
MLA	吴骏,et al."Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs".CELL PROLIFERATION 53.12(2020):e12944.